Inaktiver Wert

Atrium Innovations Inc. Aktie

Aktien

Dauer

Zeitraum

Stil

Atrium Innovations : Clinical trial shows Wobenzym® has a significant effect on exercise-induced fatigue, muscle soreness and damage in endurance athletes	15.03.17
Atrium Innovations : appoints Jason Zhang as Managing Director of Asia Pacific & Greater China	10.12.16
Atrium Innovations : Receives Nutrition Business Journal Award for Achievement in Science and Innovation	10.07.16
Atrium Innovations Inc. : Atrium Innovations Files Management Information Circular for Special Meeting of Shareholders and Convertible Debentureholders	28.12.13
Barrick Gold Corp. : GDP data, gold stocks take TSX higher	29.11.13

Manager	Titel	Alter	Seit
Eric Bouchard DFI	Director of Finance/CFO	-	-
Barry W. Ritz PRN	Corporate Officer/Principal	-	01.10.08

Aufsichtsräte	Titel	Alter	Seit
Eric Bouchard DFI	Director of Finance/CFO	-	-
Claudio Kuoni BRD	Director/Board Member	-	-
Jonathan Abikhzer BRD	Director/Board Member	-	-

Sektor

	% 1. Jan.	Kap.
ZHEJIANG NHU COMPANY LTD.	+11,85 %	8,05 Mrd.
BELLRING BRANDS, INC.	+4,94 %	7,59 Mrd.
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+2,63 %	6,07 Mrd.
THE SIMPLY GOOD FOODS COMPANY	-2,80 %	3,85 Mrd.
BYHEALTH CO., LTD	-11,22 %	3,55 Mrd.
XIAMEN KINGDOMWAY GROUP COMPANY	-7,04 %	1,28 Mrd.
HERBALIFE LTD.	-32,50 %	1,03 Mrd.
SIRIO PHARMA CO., LTD.	+12,52 %	971 Mio.
JAMIESON WELLNESS INC.	-15,69 %	813 Mio.